杏吧原创

BioNTech logo

BioNTech

BioNTech is a German company that develops immunotherapies for the treatment of cancer and other diseases.

9

Funding Rounds

$1.8b

Money raised

Overview

BioNTech is a German company that develops immunotherapies for the treatment of cancer and other diseases.
  • Websites:
  • Business model: B2B B2C
  • Headquarters: Mainz
  • Social accounts:

Funding

Funding series

Funding Series Analysis

The company BioNTech has raised a total of $1.51b in funding over 9 rounds.

Key Insights:

  • BioNTech Grant (money), September 15, 2020: $455.6m
  • BioNTech Venture round, June 29, 2020: $250m
  • BioNTech Venture round, December 17, 2019: $60.75m
  • BioNTech Grant (money), September 4, 2019: $55m
  • BioNTech Series B round, July 2019: $325m
  • BioNTech Funding Round 2018: $91.5m
  • BioNTech Series A round, January 2017: $270m
  • BioNTech funding round, January 2018: $270m
BioNTech logo
BioNTech Grant (money), September 15, 2020 $455.6m
BioNTech logo
BioNTech Venture round, June 29, 2020 $250m
BioNTech logo
BioNTech Venture round, December 17, 2019 $60.75m
BioNTech logo
BioNTech Grant (money), September 4, 2019 $55m
BioNTech logo
BioNTech Series B round, July 2019 $325m
BioNTech logo
BioNTech Funding Round 2018 $91.5m
BioNTech logo
BioNTech Series A round, January 2017 $270m
BioNTech logo
BioNTech funding round, January 2018 $270m

Industries

BioNTech is active in the following industries:

Subsidiaries

BioNTech operates through the following subsidiaries: